ASX Limited (ASX:ASX) Announces Investor Forum 2025 and Financial Guidance
ASX Limited (ASX:ASX) announces its Investor Forum 2025, detailing progress on its five-year strategy and providing financial guidance.
Tag: Earnings Reports
DGL Group (ASX:DGL) Releases FY25 Business Update
DGL Group (ASX:DGL) updates FY25 outlook, highlighting revenue growth, cost realignment, and CEO Simon Henry’s commitment to operational transformation.
Pivotal Metals Limited (ASX:PVT) Amends Gold Exploration Announcement
Pivotal Metals (ASX:PVT) amends its gold exploration announcement, adding new data and plans for the Lorraine project.
Income Asset Management Group Limited (ASX:IAM) Reports Record Q4 Revenue
Income Asset Management Group (ASX:IAM) reports a record $4.05m Q4 revenue, driven by strong DCM deals and trading activity.
New Zealand King Salmon Investments Limited (ASX:NZK) Reduces FY26 Harvest Volumes
New Zealand King Salmon Investments Limited (ASX:NZK) reduces FY26 harvest volumes, revising EBITDA guidance down significantly.
ikeGPS Group Limited (ASX:IKE) Announces FY25 Financial Results
ikeGPS Group Limited (ASX:IKE) announces a 19% revenue growth for FY25 and discusses an unsolicited acquisition offer.
Toro Energy Ltd (ASX:TOE) Announces Updated Scoping Study
Toro Energy (ASX:TOE) updates Lake Maitland Scoping Study with a pre-tax NPV of A$907.9M and a 56% IRR.
Yancoal Australia Ltd (ASX:YAL) Reports 2024 Financials and Declares Dividend at AGM
Yancoal Australia Ltd (ASX:YAL) reports robust 2024 financial performance and declares a $687 million dividend at its Annual General Meeting.
Goodman Group (ASX:GMG) Releases Q3 FY25 Operational Update
Goodman Group (ASX:GMG) reports Q3 FY25 operational progress with $13.7bn WIP and reaffirms 9% EPS growth forecast.
Neuren Pharmaceuticals (ASX:NEU) Reports Record Financial Performance and Expansion Plans
Neuren Pharmaceuticals (ASX:NEU) reports a record A$166m income in 2024, driven by DAYBUE sales and initiates Phase 3 trials for NNZ-2591.